Efficiency of Protective Interventions on Irinotecan-Induced Diarrhea: A Systematic Review and Meta-Analysis

被引:1
|
作者
He, Yanxi [1 ]
Wu, Lili [2 ]
Qi, Xiaoyi [1 ]
Wang, Xuan [1 ]
He, Bing [3 ]
Zhang, Wei [1 ]
Zhao, Wenjing [1 ,4 ]
Deng, Mingming [1 ]
Xiong, Xia [1 ]
Wang, Yu [5 ]
Liang, Sicheng [1 ,3 ,4 ,6 ,7 ]
机构
[1] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China
[2] Zunyi Med Univ, Zunyi, Peoples R China
[3] Southwest Med Univ, Luzhou, Peoples R China
[4] Human Microecol & Precis Diag & Treatment Luzhou K, Luzhou, Peoples R China
[5] Gulin Cty Peoples Hosp, Luzhou 646000, Peoples R China
[6] Cardiovasc & Metab Dis Sichuan Key Lab, Luzhou, Peoples R China
[7] Southwest Med Univ, Affiliated Hosp, Dept Gastroenterol, Luzhou 646000, Peoples R China
基金
中国国家自然科学基金;
关键词
irinotecan; diarrhea; prevention; systematic review; meta-analysis; METASTATIC COLORECTAL-CANCER; PHASE-II; ACTIVATED-CHARCOAL; DOUBLE-BLIND; INDUCTION CHEMOTHERAPY; HERBAL MEDICINE; CPT-11; INHIBITION; FOLFIRI; PLACEBO;
D O I
10.1177/15347354241242110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Irinotecan is widely used in the treatment of various solid tumors, but the adverse effects from it, especially diarrhea, limit its use. Several clinical trials of prophylactic treatment of irinotecan-induced diarrhea (IID) have been ongoing, and some of the data are controversial. This encouraged us to conduct a meta-analysis of the effects of interventions on preventing IID. Method: This systematic review was conducted based on the PRISMA statement. We performed literature searches from PubMed, Web of Science, Embase, and Cochrane Library. The number registered in PROSPERO is CRD42022368633. After searching 1034 articles in the database and references, 8 studies were included in this meta-analysis. Result: The RR of high-grade diarrhea and all-grade diarrhea were 0.31 (I-2 = 51%, 95% CI: 0.14-0.69; P = .004) and .76 (I-2 = 65%, 95% CI: 0.62-0.93; P < .008) respectively, thus the use of intervention measures for preventing IID is effective, and the risk reduction of high-grade diarrhea was more significant. Subgroup analysis revealed that the monotherapy group (RR: 0.48, 95% CI: 0.21-1.13, I-2 = 0%) and combination therapy group (RR: 0.14, 95% CI: 0.06-0.32, I-2 = 0%) in the risk of high-grade diarrhea had no significant heterogeneity within the groups, and traditional herbal medicines (Kampo medicine Hangeshashin-to, PHY906 and hot ironing with Moxa Salt Packet on Tianshu and Shangjuxu) were effective preventive measures (RR:0.20, 95% CI: 0.07-0.60, I-2 = 0%). The Jadad scores for traditional herbal medicines studies were 3, and the follow-up duration was only 2 to 6 weeks.<br /> Conclusion: This systematic review and meta-analysis suggest that preventive treatments significantly reduced the risk of high-grade and all-grade diarrhea, confirming the efficacy in the incidence and severity of IID, among which traditional herbal medicines (baicalin-containing) provided a protective effect in reducing the severity of IID. However, the traditional herbal medicines studies were of low quality. Combined irinotecan therapy can obtain better preventive effects than monotherapy of IID. These would be helpful for the prevention of IID in clinical practice.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Chinese herbal medicine for irinotecan-induced diarrhea: A systematic review and meta-analysis
    Lin, Xiaoli
    Fang, Yu
    Cheng, Yuan
    Wang, Qiaoling
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2024, 20 (02) : 158 - 167
  • [2] UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis
    Zhang, Xue
    Yin, Jia-Fu
    Zhang, Jiao
    Kong, Shu-Jia
    Zhang, Hong-Yin
    Chen, Xue-Mei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 135 - 149
  • [3] UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis
    Xue Zhang
    Jia-Fu Yin
    Jiao Zhang
    Shu-Jia Kong
    Hong-Yin Zhang
    Xue-Mei Chen
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 135 - 149
  • [4] Herbal Medicines for Irinotecan-Induced Diarrhea
    Tang, Liu
    Li, Xiaolei
    Wan, Liping
    Xiao, Yao
    Zeng, Xin
    Ding, Hong
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [5] Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses
    Campbell, J. M.
    Stephenson, M. D.
    Bateman, E.
    Peters, M. D. J.
    Keefe, D. M.
    Bowen, J. M.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 21 - 28
  • [6] Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses
    J M Campbell
    M D Stephenson
    E Bateman
    M D J Peters
    D M Keefe
    J M Bowen
    The Pharmacogenomics Journal, 2017, 17 : 21 - 28
  • [7] Neomycin as secondary prophylaxis for irinotecan-induced diarrhea
    Schmittel, A
    Jahnke, K
    Thiel, E
    Keilholz, U
    ANNALS OF ONCOLOGY, 2004, 15 (08) : 1296 - 1296
  • [8] Mechanisms and emerging strategies for irinotecan-induced diarrhea
    Xu, Shengkun
    Lan, Huiyin
    Huang, Chengyi
    Ge, Xingnan
    Zhu, Ji
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 974
  • [9] Oral probiotic supplementation to alleviate diarrhea induced by fluoropyrimidines or irinotecan-based chemotherapy: A systematic review and meta-analysis
    Siritientong, Tippawan
    Thet, Daylia
    Leelakanok, Nattawut
    Areepium, Nutthada
    COMPLEMENTARY THERAPIES IN MEDICINE, 2025, 89
  • [10] Activated charcoal to prevent irinotecan-induced diarrhea in children
    Sergio, Gallegos-Castorena
    Felix, Gaytan-Morales
    Luis, Juarez-Villegas
    PEDIATRIC BLOOD & CANCER, 2008, 51 (01) : 49 - 52